Novoste Corporation Exhibit 11
Computation of Net Loss Per Share
Three Months Ended Six Months Ended
June 30, June 30,
-------------------------------- --------------------------------
1997 1996 1997 1996
----------- ----------- ----------- -----------
Weighted average number of
shares of common stock
outstanding during the period .................. 8,453,621 5,744,241 8,393,106 4,927,140
Effect of common stock issued
and stock options and warrants
granted during the 12-month
period preceding April 11,
1996(1) ........................................ -- -- -- 597,205
Elimination of duplicative
effect of including the same
shares in both amounts
above .......................................... -- -- -- (434,634)
----------- ----------- ----------- -----------
Total common and common
equivalent shares .............................. 8,453,621 5,744,241 8,393,106 5,089,711
=========== =========== =========== ===========
Net loss ....................................... ($3,405,322) ($1,273,326) ($6,047,728) ($2,483,987)
=========== =========== =========== ===========
Net loss per share (2)
Primary .................................... ($ 0.40) ($ 0.22) ($ 0.72) ($ 0.49)
=========== =========== =========== ===========
Fully Diluted .............................. ($ 0.40) ($ 0.22) ($ 0.72) ($ 0.49)
=========== =========== =========== ===========
(1) Pursuant to Securities and Exchange Commission Staff Accounting Bulletin
No. 83, Common Stock issued and stock options and warrants granted at
prices below the initial public offering price per share during the
12-month period immediately preceding the initial filing date of the
Company's Registration Statement for its initial public offering have been
included as outstanding for all periods presented which include periods
prior to such filing date using the treasury stock method.
(2) Since the impact of including common stock equivalents is anti-dilutive for
both primary and fully diluted loss per share, the calculation of loss per
share for both purposes is identical.